Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 611
Filter
1.
J Mol Endocrinol ; 72(1)2024 Jan 01.
Article in English | MEDLINE | ID: mdl-37855323

ABSTRACT

Excess growth hormone (GH) has been implicated in multiple cancer types and there is increasing interest in the development of therapeutic inhibitors targeting GH-GH receptor (GHR) signalling. Here we describe a panel of anti-GH monoclonal antibodies (mAbs) generated using a hybridoma approach and identify two novel inhibitory mAbs (1-8-2 and 1-46-3) that neutralised GH signalling. mAbs 1-8-2 and 1-46-3 exhibited strong inhibitory activity against GH-dependent cell growth in a Ba/F3-GHR cell viability assay, with EC50 values of 1.00 ± 0.27 and 0.5 ± 0.1 µg/mL, respectively. Cross-reactivity with the human placental hormones, placental lactogen (PL) and placental GH, was observed by ELISA, but neither antibody cross-reacted with mouse GH or human prolactin (PRL). mAb 1-8-2 had a binding affinity for GH of KD 0.62 ± 0.5 nM, while mAb 1-46-3 had a KD of 2.68 ± 0.53 nM, as determined by bio-layer interferometry. mAb 1-46-3 inhibited GH-dependent signal transduction in T-47D and LNCaP cancer cell lines and reduced GH-dependent cell growth and migration in the breast cancer cell line T-47D. mAb 1-46-3 inhibited T-47D cell viability more effectively than the GHR antagonist B2036. In conclusion, we describe two novel inhibitory anti-GH mAbs and provide in vitro evidence supporting development of these entities as anti-cancer therapeutics.


Subject(s)
Antibodies, Monoclonal , Growth Hormone , Animals , Female , Humans , Mice , Pregnancy , Antibodies, Monoclonal/pharmacology , Cell Line , Growth Hormone/immunology , Placenta/metabolism , Receptors, Somatotropin/metabolism , Signal Transduction
2.
Fish Shellfish Immunol ; 106: 887-897, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32866610

ABSTRACT

An energy trade-off is existed between immunological competence and growth. The axis of growth hormone releasing hormone, somatostatin, growth hormone, insulin-like growth factor (GHRH-SST-GH-IGF axis) regulates growth performances and immune competences in rainbow trout (Oncorhynchus mykiss). The salmonid-specific whole genome duplication event is known to result in duplicated copies of several key genes in GHRH-SST-GH-IGF axis. In this study, we evaluated the physiological functions of GHRH-SST-GH-IGF axis in regulating crosstalk between growth and immunity. Based on principal components analysis (PCA), we observed the overall expression profiles of GHRH-SST-GH-IGF axis were significantly altered by Vibrio anguillarum infection. Trout challenged with Vibrio anguillarum showed down-regulated igf1s subtypes and up-regulated igfbp1a1. The brain sst genes (sst1a, sst1b, sst3b and sst5) and igfpbs genes (igfbp4s and igfbp5b2) were significantly affected by V. anguillarum infection, while the igfbp4s, igfbp5s, igfbp6s and igf2bps genes showed significant changes in peripheral immune tissues in response to V. anguillarum infection. Gene enrichment analyses showed functional and signaling pathways associated with apoptosis (such as p53, HIF-1 or FoxO signaling) were activated. We further proposed a possible model that describes the IGF and IGFBPs-regulated interaction between cell growth and programmed death. Our study provided new insights into the physiological functions and potentially regulatory mechanisms of the GHRH-SST-GH-IGF axis, indicating the pleiotropic effects of GHRH-SST-GH-IGF axis in regulating crosstalk between growth and immunity in trout.


Subject(s)
Fish Diseases/immunology , Growth Hormone-Releasing Hormone/immunology , Growth Hormone/immunology , Oncorhynchus mykiss/growth & development , Oncorhynchus mykiss/immunology , Somatostatin/immunology , Vibrio Infections/immunology , Vibrio , Animals , Brain/immunology , Fish Diseases/genetics , Oncorhynchus mykiss/microbiology , Signal Transduction , Somatomedins/genetics , Somatomedins/immunology , Somatostatin/genetics , Vibrio Infections/genetics , Vibrio Infections/veterinary
3.
J Immunol ; 205(3): 776-788, 2020 08 01.
Article in English | MEDLINE | ID: mdl-32591394

ABSTRACT

Growth hormone (GH), a pleiotropic hormone secreted by the pituitary gland, regulates immune and inflammatory responses. In this study, we show that GH regulates the phenotypic and functional plasticity of macrophages both in vitro and in vivo. Specifically, GH treatment of GM-CSF-primed monocyte-derived macrophages promotes a significant enrichment of anti-inflammatory genes and dampens the proinflammatory cytokine profile through PI3K-mediated downregulation of activin A and upregulation of MAFB, a critical transcription factor for anti-inflammatory polarization of human macrophages. These in vitro data correlate with improved remission of inflammation and mucosal repair during recovery in the acute dextran sodium sulfate-induced colitis model in GH-overexpressing mice. In this model, in addition to the GH-mediated effects on other immune cells, we observed that macrophages from inflamed gut acquire an anti-inflammatory/reparative profile. Overall, these data indicate that GH reprograms inflammatory macrophages to an anti-inflammatory phenotype and improves resolution during pathologic inflammatory responses.


Subject(s)
Cellular Reprogramming/immunology , Colitis/immunology , Gene Expression Regulation/immunology , Growth Hormone/immunology , Macrophages/immunology , MafB Transcription Factor/immunology , Animals , Cattle , Cellular Reprogramming/genetics , Colitis/chemically induced , Colitis/genetics , Dextran Sulfate/toxicity , Disease Models, Animal , Growth Hormone/genetics , MafB Transcription Factor/genetics , Mice , Mice, Transgenic
4.
Int J Mol Sci ; 21(4)2020 Feb 20.
Article in English | MEDLINE | ID: mdl-32093298

ABSTRACT

It is known that growth hormone (GH) is expressed in immune cells, where it exerts immunomodulatory effects. However, the mechanisms of expression and release of GH in the immune system remain unclear. We analyzed the effect of growth hormone-releasing hormone (GHRH), thyrotropin-releasing hormone (TRH), ghrelin (GHRL), and somatostatin (SST) upon GH mRNA expression, intracellular and released GH, Ser133-phosphorylation of CREB (pCREBS133), intracellular Ca2+ levels, as well as B-cell activating factor (BAFF) mRNA expression in bursal B-lymphocytes (BBLs) cell cultures since several GH secretagogues, as well as their corresponding receptors (-R), are expressed in B-lymphocytes of several species. The expression of TRH/TRH-R, ghrelin/GHS-R1a, and SST/SST-Rs (Subtypes 1 to 5) was observed in BBLs by RT-PCR and immunocytochemistry (ICC), whereas GHRH/GHRH-R were absent in these cells. We found that TRH treatment significantly increased local GH mRNA expression and CREB phosphorylation. Conversely, SST decreased GH mRNA expression. Additionally, when added together, SST prevented TRH-induced GH mRNA expression, but no changes were observed in pCREBS133 levels. Furthermore, TRH stimulated GH release to the culture media, while SST increased the intracellular content of this hormone. Interestingly, SST inhibited TRH-induced GH release in a dose-dependent manner. The coaddition of TRH and SST decreased the intracellular content of GH. After 10 min. of incubation with either TRH or SST, the intracellular calcium levels significantly decreased, but they were increased at 60 min. However, the combined treatment with both peptides maintained the Ca2+ levels reduced up to 60-min. of incubation. On the other hand, BAFF cytokine mRNA expression was significantly increased by TRH administration. Altogether, our results suggest that TRH and SST are implicated in the regulation of GH expression and release in BBL cultures, which also involve changes in pCREBS133 and intracellular Ca2+ concentration. It is likely that TRH, SST, and GH exert autocrine/paracrine immunomodulatory actions and participate in the maturation of chicken BBLs.


Subject(s)
Avian Proteins/immunology , B-Lymphocytes/immunology , Bursa of Fabricius/immunology , Chickens/immunology , Ghrelin/immunology , Growth Hormone-Releasing Hormone/immunology , Growth Hormone/immunology , Somatostatin/immunology , Thyrotropin-Releasing Hormone/immunology , Animals , B-Lymphocytes/cytology , Bursa of Fabricius/cytology , Cell Culture Techniques , Cells, Cultured
5.
Fish Shellfish Immunol ; 97: 656-668, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31891812

ABSTRACT

AquAdvantage Salmon (growth hormone transgenic female triploid Atlantic salmon) are a faster-growing alternative to conventional farmed diploid Atlantic salmon. To investigate optimal rearing conditions for their commercial production, a laboratory study was conducted in a freshwater recirculating aquaculture system (RAS) to examine the effect of rearing temperature (10.5 °C, 13.5 °C, 16.5 °C) on their antiviral immune and stress responses. When each temperature treatment group reached an average weight of 800 g, a subset of fish were intraperitoneally injected with either polyriboinosinic polyribocytidylic acid (pIC, a viral mimic) or an equal volume of sterile phosphate-buffered saline (PBS). Blood and head kidney samples were collected before injection and 6, 24 and 48 h post-injection (hpi). Transcript abundance of 7 antiviral biomarker genes (tlr3, lgp2, stat1b, isg15a, rsad2, mxb, ifng) was measured by real-time quantitative polymerase chain reaction (qPCR) on head kidney RNA samples. Plasma cortisol levels from blood samples collected pre-injection and from pIC and PBS groups at 24 hpi were quantified by ELISA. While rearing temperature and treatment did not significantly affect circulating cortisol, all genes tested were significantly upregulated by pIC at all three temperatures (except for tlr3, which was only upregulated in the 10.5 °C treatment). Target gene activation was generally observed at 24 hpi, with most transcript levels decreasing by 48 hpi in pIC-injected fish. Although a high amount of biological variability in response to pIC was evident across all treatments, rearing temperature significantly influenced transcript abundance and/or fold-changes comparing time- and temperature-matched pIC- and PBS-injected fish for several genes (tlr3, lgp2, stat1b, isg15a, rsad2 and ifng) at 24 hpi. As an example, significantly higher fold-changes of rsad2, isg15a and ifng were found in fish reared at 10.5 °C when compared to 16.5 °C. Multivariate analysis confirmed that rearing temperature modulated antiviral immune response. The present experiment provides novel insight into the relationship between rearing temperature and innate antiviral immune response in AquAdvantage Salmon.


Subject(s)
Growth Hormone/immunology , Immunity, Innate , Salmo salar/immunology , Temperature , Triploidy , Animals , Animals, Genetically Modified/genetics , Animals, Genetically Modified/immunology , Aquaculture/methods , Female , Gene Expression/immunology , Growth Hormone/genetics , Interferon Inducers/administration & dosage , Interferon Inducers/immunology , Poly I-C/administration & dosage , Poly I-C/immunology , Salmo salar/genetics , Stress, Physiological/drug effects , Virus Diseases/immunology , Virus Diseases/veterinary
6.
Curr Protein Pept Sci ; 21(1): 52-65, 2020.
Article in English | MEDLINE | ID: mdl-31702489

ABSTRACT

Hormones are known to influence various body systems that include skeletal, cardiac, digestive, excretory, and immune systems. Emerging investigations suggest the key role played by secretions of endocrine glands in immune cell differentiation, proliferation, activation, and memory attributes of the immune system. The link between steroid hormones such as glucocorticoids and inflammation is widely known. However, the role of peptide hormones and amino acid derivatives such as growth and thyroid hormones, prolactin, dopamine, and thymopoietin in regulating the functioning of the immune system remains unclear. Here, we reviewed the findings pertinent to the functional role of hormone-immune interactions in health and disease and proposed perspective directions for translational research in the field.


Subject(s)
Endocrine System Diseases/metabolism , Endocrine System/metabolism , Growth Hormone/metabolism , Immune System Diseases/metabolism , Immune System/metabolism , Prolactin/metabolism , Thymocytes/metabolism , Animals , Cell Communication , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Dopamine/genetics , Dopamine/immunology , Dopamine/metabolism , Endocrine System/cytology , Endocrine System/immunology , Endocrine System Diseases/genetics , Endocrine System Diseases/immunology , Endocrine System Diseases/pathology , Glucocorticoids/genetics , Glucocorticoids/immunology , Glucocorticoids/metabolism , Growth Hormone/genetics , Growth Hormone/immunology , Humans , Immune System/cytology , Immune System/immunology , Immune System Diseases/genetics , Immune System Diseases/immunology , Immune System Diseases/pathology , Lactotrophs/cytology , Lactotrophs/immunology , Lactotrophs/metabolism , Prolactin/genetics , Prolactin/immunology , Receptors, Dopamine/genetics , Receptors, Dopamine/immunology , Receptors, Dopamine/metabolism , Somatotrophs/cytology , Somatotrophs/immunology , Somatotrophs/metabolism , Thymocytes/cytology , Thymocytes/immunology , Thyroid Hormones/genetics , Thyroid Hormones/immunology , Thyroid Hormones/metabolism
7.
Prensa méd. argent ; 105(5): 253-258, jun 2019. tab
Article in Spanish | LILACS, BINACIS | ID: biblio-1024402

ABSTRACT

El presente trabajo realiza una investigación bibliográfica sobre el uso clínico de RhGH en pacientes adultos HIV en su rol inmunomodulador mediante búsqueda booleana en Pubmed de los términos RhGH yHIV en artículos de ensayos clínicos, únicamente en adultos a partir de los 19 o más años de edad hasta enero del 2019


Subject(s)
Humans , Adult , Middle Aged , Aged , Aged, 80 and over , Research/statistics & numerical data , Growth Hormone/administration & dosage , Growth Hormone/immunology , HIV/immunology , Clinical Trial , Anti-Retroviral Agents/therapeutic use , Immune System/metabolism
8.
Front Immunol ; 9: 2175, 2018.
Article in English | MEDLINE | ID: mdl-30333823

ABSTRACT

The precise impact of the somatotrope axis upon the immune system is still highly debated. We have previously shown that mice with generalized ablation of growth hormone (GH) releasing hormone (GHRH) gene (Ghrh-/-) have normal thymus and T-cell development, but present a marked spleen atrophy and B-cell lymphopenia. Therefore, in this paper we have investigated vaccinal and anti-infectious responses of Ghrh-/- mice against S. pneumoniae, a pathogen carrying T-independent antigens. Ghrh-/- mice were unable to trigger production of specific IgM after vaccination with either native pneumococcal polysaccharides (PPS, PPV23) or protein-PPS conjugate (PCV13). GH supplementation of Ghrh-/- mice restored IgM response to PPV23 vaccine but not to PCV13 suggesting that GH could exert a specific impact on the spleen marginal zone that is strongly implicated in T-independent response against pneumococcal polysaccharides. As expected, after administration of low dose of S. pneumoniae, wild type (WT) completely cleared bacteria after 24 h. In marked contrast, Ghrh-/- mice exhibited a dramatic susceptibility to S. pneumoniae infection with a time-dependent increase in lung bacterial load and a lethal bacteraemia already after 24 h. Lungs of infected Ghrh-/- mice were massively infiltrated by inflammatory macrophages and neutrophils, while lung B cells were markedly decreased. The inflammatory transcripts signature was significantly elevated in Ghrh-/- mice. In this animal model, the somatotrope GHRH/GH/IGF1 axis plays a vital and unsuspected role in vaccine and immunological defense against S. pneumoniae.


Subject(s)
B-Lymphocytes/immunology , Growth Hormone-Releasing Hormone/immunology , Growth Hormone/deficiency , Pneumococcal Vaccines/immunology , Signal Transduction/immunology , Streptococcus pneumoniae/immunology , Animals , B-Lymphocytes/pathology , Growth Hormone/immunology , Growth Hormone-Releasing Hormone/genetics , Immunoglobulin M/genetics , Immunoglobulin M/immunology , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/immunology , Lung/immunology , Lung/pathology , Mice , Mice, Knockout , Signal Transduction/genetics
9.
Growth Horm IGF Res ; 42-43: 58-65, 2018.
Article in English | MEDLINE | ID: mdl-30227383

ABSTRACT

Human (h) pituitary growth hormone (GH) is both physiologically and clinically important. GH reaches its highest circulatory levels in puberty, where it contributes to energy homeostasis and somatogenic growth. GH also helps to maintain tissues and organs and, thus, health and homeostasis. A reduction in the rate of hGH production begins in middle age but if GH insufficiency occurs this may result in tissue degenerative and metabolic diseases. As a consequence, hGH is prescribed under conditions of GH deficiency and, because of its lipolytic activity, stimulation of hGH release has also been used to treat obesity. However, studies of normal GH production and particularly synthesis versus secretion are not feasible in humans as they require sampling normal pituitaries from living subjects. Furthermore, human (or primate) GH structure and, as such, regulation and potential function, is distinct from non-primate rodent GH. As a result, most information about hGH regulation comes from measurements of secreted levels of GH in humans. Thus, partially humanized hGH transgenic mice, generated containing fragments of human chromosome 17 that include the intact hGH gene locus and many thousands of flanking base pairs as well as the endogenous mouse (m) GH gene provide a potentially useful model. Here we review this mouse model in terms of its ability to allow comparison of hGH versus mGH gene expression, and specifically: (i) GH locus structure as well as regulated and rhythmic expression; (ii) their ability to model a clinical assessment of hGH production in response to overeating and hyperinsulinemia as well as a possible effect of exercise, and (iii) their hGH-related immune tolerance and thus potential for testing hGH-related analogue immunogenicity.


Subject(s)
Chromosomes/chemistry , Gene Expression Regulation , Growth Hormone/analogs & derivatives , Growth Hormone/genetics , Immune Tolerance , Models, Biological , Animals , Growth Hormone/immunology , Humans , Mice
10.
Usp Fiziol Nauk ; 48(1): 80-90, 2017.
Article in Russian | MEDLINE | ID: mdl-29283520

ABSTRACT

The review provides information about the features of the sensitivity of thymocytes, lymphoid organs' cells and T-lymphocytes of peripheral blood to the hormones secreted by anterior pituitary gland's cells: growth hormone, thyrotropin, adrenocorticotropic hormone, prolactin and ß-endorphin. Some aspects of the T-lymphocytes's response to humoral signals from the hypophysis are shown in the article. Also the pituitary hormones' role in the regulation of proliferation, differentiation, and cytokine production of T-lymphocytes in normal and pathological conditions of the organism being discussed.


Subject(s)
Adrenocorticotropic Hormone/pharmacology , Growth Hormone/pharmacology , Pituitary Gland, Anterior/metabolism , Prolactin/pharmacology , Thymocytes/drug effects , Thyrotropin/pharmacology , beta-Endorphin/pharmacology , Adrenocorticotropic Hormone/genetics , Adrenocorticotropic Hormone/immunology , Animals , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Gene Expression Regulation , Growth Hormone/genetics , Growth Hormone/immunology , Humans , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Primary Cell Culture , Prolactin/genetics , Prolactin/immunology , Signal Transduction , Thymocytes/cytology , Thymocytes/immunology , Thyrotropin/genetics , Thyrotropin/immunology , beta-Endorphin/genetics , beta-Endorphin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL